Market and Trading Information for Celldex Therapeutics
The following details were available for trading and market data about the stock of Celldex Therapeutics as of writing:
Trading Details of Celldex Therapeutics (CLDX)
Current Share Price:
$39.07
Previous Year's Closing Price:
$39.66
Percentage Price Change (YTD):
-1.49%
Market Cap:
$2.58 billion
52-week Price Range:
$22.11 - $53.18
Dividend Per Share:
$0
EPS (TTM):
-2.92
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
-12.64
Company Profile and Business Description for Celldex Therapeutics
Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. The Company is using the technologies to develop targ...to see full details, pleaseLogin / Register to view.
ETFs Holding Celldex Therapeutics Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Celldex Therapeutics stocks in their respective portfolios. See Full List.
The iShares Core S&P Total U.S. Stock Market ETF tracks a market cap-weighted index of all common equities listed on the NYSE and the NASDAQ. ...Full Details
The iShares Microcap ETF tracks a market-cap-weighted index of U.S. micro-cap stocks. The index selects the smallest 1000 stocks in the Russell 2000 Index. ...Full Details
The Invesco FTSE RAFI US 1500 Small-Mid ETF tracks a fundamentally weighted index of 1,500 small- and midcap companies in the FTSE USA All Cap Index. ...Full Details
The Vanguard Total Stock Market ETF tracks a cap-weighted index that measures the investable US equities market, encompassing the entire market-cap spectrum. ...Full Details ...Candlestick Patterns.
See Full List of ETFs holding Celldex Therapeutics stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Biotech In Vitro In Vivo Diagnostics Sector
Along with Celldex Therapeutics, Inc., the following other peer (competitor) companies also exist within the same Biotech In Vitro In Vivo Diagnostics - Healthcare sector whose company profile and dividend history is as follows:
▶ Akers Biosciences (AKER): Akers Biosciences, Inc., incorporated on March 9, 1989, develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Companys product ....See Detailed Company Profile, Dividend History
▶ ARCA biopharma (ABIO): ARCA biopharma, Inc. (ARCA), incorporated on March 16, 2004, is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Companys lead product candidate ....See Detailed Company Profile, Dividend History
▶ IDEXX Laboratories (IDXX): IDEXX Laboratories, Inc., incorporated on December 19, 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing markets. ....See Detailed Company Profile, Dividend History
▶ ImmuCell (ICCC): ImmuCell Corporation, incorporated on February 9, 1987, is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity ....See Detailed Company Profile, Dividend History
▶ Immunomedics (IMMU): Immunomedics, Inc., incorporated on July 6, 1982, is a clinical-stage biopharmaceutical company, which is engaged in researching, developing, manufacturing and marketing biopharmaceutical products. It develops monoclonal antibody-based products for the ....See Detailed Company Profile, Dividend History
▶ Intellia Therapeutics (NTLA): Intellia Therapeutics, Inc., incorporated on May 7, 2014, is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome ....See Detailed Company Profile, Dividend History
▶ Lantheus (LNTH): Lantheus Holdings, Inc., incorporated on November 30, 2007, is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and ....See Detailed Company Profile, Dividend History
▶ Meridian Bioscience (VIVO): Meridian Bioscience, Inc., incorporated on June 25, 1976, is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, ....See Detailed Company Profile, Dividend History
▶ Myriad Genetics (MYGN): Myriad Genetics, Inc. (Myriad), incorporated on November 6, 1992, is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The ....See Detailed Company Profile, Dividend History
▶ Navidea BioPharma (NAVB): Navidea Biopharmaceuticals, Inc. (Navidea), incorporated on April 28, 1988, is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple ....See Detailed Company Profile, Dividend History
▶ Neogen (NEOG): Neogen Corporation, incorporated on June 30, 1981, develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food ....See Detailed Company Profile, Dividend History
▶ Nymox Pharmaceutical (NYMX): Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of ....See Detailed Company Profile, Dividend History
▶ OncoCyte (OCX): OncoCyte Corporation (OncoCyte), incorporated on September 30, 2009, is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery ....See Detailed Company Profile, Dividend History
▶ Oxford Immunotec Global (OXFD): Oxford Immunotec Global PLC, incorporated on August 16, 2013, is a diagnostics company. The Company is focused on developing and commercializing tests for under-served immune-regulated conditions. The Companys product lines ....See Detailed Company Profile, Dividend History
▶ Quidel (QDEL): Quidel Corporation, incorporated on July 14, 1987, is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, ....See Detailed Company Profile, Dividend History
▶ Quotient (QTNT): Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwi....See Detailed Company Profile, Dividend History
▶ Trinity Biotech (TRIB): Trinity Biotech plc (Trinity Biotech), incorporated on January 22, 1992, develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. ....See Detailed Company Profile, Dividend History
▶ Vermillion (VRML): Vermillion, Inc., incorporated on May 23, 2000, is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic ....See Detailed Company Profile, Dividend History
▶ VolitionRX (VNRX): VolitionRx Limited, incorporated on September 24, 1998, is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. ....See Detailed Company Profile, Dividend History